To alleviate this unacceptable disease trajectory, recent studies have focused on immunotherapy of multiple cancers targetingprogrammed cell death-1 (PD-1) or programmed death-ligand-1 (PD-L1) [2, 3]. The gene discussed is CD274; the disease is cancer.